tradingkey.logo
tradingkey.logo
Suchen

Revvity Inc

RVTY
Zur Watchlist hinzufügen
113.550USD
+7.920+7.50%
Trading geöffnet ETKurse um 15 Minuten verzögert
12.75BMarktkapitalisierung
54.54KGV TTM

mehr Informationen über Revvity Inc Unternehmen

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Revvity Inc Informationen

BörsenkürzelRVTY
Name des UnternehmensRevvity Inc
IPO-datumAug 12, 2101
CEOSingh (Prahlad R)
Anzahl der mitarbeiter11000
WertpapierartOrdinary Share
GeschäftsjahresendeAug 12
Addresse77 4Th Avenue
StadtWALTHAM
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl02451
Telefon17816636900
Websitehttps://www.revvity.com/
BörsenkürzelRVTY
IPO-datumAug 12, 2101
CEOSingh (Prahlad R)

Führungskräfte von Revvity Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
113.31K
+14.54%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
63.77K
+4.21%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
41.51K
+9.21%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
28.29K
+8.06%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
18.12K
+21.16%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
16.41K
-38.94%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
15.98K
+14.26%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
13.96K
+25.23%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
7.37K
+30.94%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
7.37K
+30.94%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
113.31K
+14.54%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
63.77K
+4.21%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
41.51K
+9.21%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
28.29K
+8.06%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
18.12K
+21.16%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
16.41K
-38.94%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Revvity Inc?

Die fünf größten Anteilseigner von Revvity Inc sind: Dr. Prahlad R. Singh, Ph.D.

Wie viele Institutionen halten Anteile an Revvity Inc (RVTY)?

Mit Stand vom 2026Q1 halten 1187 Institutionen Anteile an Revvity Inc, mit einem Gesamtmarktwert von etwa 116.42M, was 104.13% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -12219072.00 gestiegen.
KeyAI